当前位置: 首页 » 论文全文
←返回首页
期刊信息:
《药学服务与研究》2018年, 第18卷, 第6期, 第423,433,469页
标题:
肾功能亢进对感染性休克患者万古霉素剂量的影响
DOI:
10.5428/pcar20180607
作者:
1. 钟晗1(1.上海交通大学医学院附属仁济医院药学部 上海 200127 hannahzhong22@gmail.com)
2. 张在丽1(1.上海交通大学医学院附属仁济医院药学部 上海 200127 )
3. 崔敏1(1.上海交通大学医学院附属仁济医院药学部 上海 200127 )
4. 赵贤元2(2.上海交通大学医学院附属仁济医院重症医学科 上海 200127 )
5. 王永辉3(3.河南省驻马店市中心医院药学部 河南驻马店 463000 wangyong hui400@163.com)
摘要:
欢迎阅读《药学服务与研究》!您是该文第 338 位读者!
若需在您的论文中引用此文,请按以下格式著录参考文献:
中文著录格式 钟晗1,张在丽1,崔敏1,赵贤元2,王永辉3. 肾功能亢进对感染性休克患者万古霉素剂量的影响[J]. 药学服务与研究. 2018; 18(6): 423,433,469.
英文著录格式 ZHONG Han,ZHANG ZaiLi,CUI Min,et al. Effect of hyperfunction of kidney on vancomycin dosage in patients with septic shock[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(6): 423,433,469.
参考文献:
1. Rhodes A,Evans L E,Alhazzani W,et al.Surviving sepsis campaign:international guidelines for management of sepsis and septic shock:2016[J].Intensive Care Med,2017,43(3):304-377.
2. CHU Yang,LUO YiFan,QU LianYue,et al.Application of vancomycin in patients with varying renal function,especially those with augmented renal clearance[J].Pharm Biol,2016,54(12):2802-2806.
3. Solomkin J S,Mazuski J E,Bradley J S,et al.Diagnosis and management of complicated intra-abdominal infection in adults and children:guidelines by the Surgical Infection Society and the Infectious Diseases Society of America[J].Clin Infect Dis,2010,50(2):133-164.
4. YE ZhiKang,CHEN YaoLong,CHEN Ken,et al.Therapeutic drug monitoring of vancomycin:a guideline of the Division of Therapeutic Drug Monitoring,Chinese Pharmacological Society[J].J Antimicrob Chemother,2016,71(11):3020-3025.
5. Bilbao-Meseguer I,Rodríguez-Gascón A,Barrasa H,et al.Augmented renal clearance in critically ill patients:a systematic review[J].Clin Pharmacokinet,2018,57(9):1107-1121.
6. Claus B O M,Hoste E A,Colpaert K,et al.Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy[J].J Crit Care,2013,28(5):695-700.
7. Carlier M,Carrette S,Roberts J A,et al.Meropenem and piperacillin/tazobactam prescribing in critically ill patients:does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?[J].Crit Care,2013,17(3):r84.
8. Udy A A,Lipman J,Jarrett P,et al.Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?[J].Crit Care,2015,19(1):28.
9. Baptista J P,Roberts J A,Sousa E,et al.Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients:developing and testing of a dosing nomogram[J].Crit Care,2014,18(6):654.
10. Baptista J P,Sousa E,Martins P J,et al.Augmented renal clearance in septic patients and implications for vancomycin optimisation[J].Int J Antimicrob Agents,2012,39(5):420-423.
11. Sime F B,Udy A A,Roberts J A.Augmented renal clearance in critically ill patients:etiology,definition and implications for beta-lactam dose optimization[J].Curr Opin Pharmacol,2015,24:1-6.
12. Shimamoto Y,Fukuda T,Tanaka K,et al.Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis[J].Intensive Care Med,2013,39(7):1247-1252.